eMedicine Specialties > Radiology > Genitourinary

Urachal Carcinoma

Robert L Cirillo Jr, MD, MBA, Assistant Professor of Radiology, Florida State University College of Medicine; Medical Interventional Radiologist, Director/CEO, South Georgia Vascular Institute and South Georgia Laser Vein Center
Contributor Information and Disclosures

Updated: Jul 29, 2004

Introduction

Background

Urachal carcinoma is a rare cancer accounting for less than 0.7% of bladder cancers. Commonly, urachal carcinoma arises in the dome of the urinary bladder at the vesicourachal junction. The tumor commonly invades the anterior abdominal wall, and most patients have a poor prognosis. Approximately 85% of urachal carcinomas are adenocarcinomas, and these are 40% of bladder adenocarcinomas.

For excellent patient education resources, visit eMedicine's Cancer and Tumors Center. Also, see eMedicine's patient education article, Bladder Cancer.

Pathophysiology

The pathogenesis of urachal carcinoma is poorly understood. Adenocarcinoma is believed to arise from malignant transformation of columnar metaplasia in as many as 84% of patients. However, in 3%, it arises within the transitional cell epithelium, and the transitional epithelium undergoes metaplasia to become glandular epithelium. Approximately 70% of urachal carcinomas are mucin-producing adenocarcinomas, and 15% are non–mucin-producing adenocarcinomas.

Frequency

United States

Urachal carcinomas are rare.

Mortality/Morbidity

Mortality is based on the stage at presentation. The prognosis with urachal carcinoma is poor compared with that of other types of bladder carcinomas. Early detection is important in preventing death because urachal cancers that are found early have a good prognosis. However, in 50% of patients, the disease is fatal. The 5-year survival rate of less than 16%. The poor prognosis is a result of the late presentation of symptoms, a tendency for early local invasion, and pulmonary and osseous metastasis.

Sex

Approximately 75% of urachal carcinoma cases occur in men.

Age

Patients usually are aged 40-70 years.

Anatomy

The urachus is a musculofibrous band that is an extension of the urogenital sinus. This band extends from the bladder dome to the umbilicus; in the fetus, it is contiguous with the allantois. The urachus lies in the space of Retzius, between the transversalis fascia anteriorly and the peritoneum posteriorly. In 70% of adults, a small lumen lined by transitional epithelium remains in the urachus. The persistence of a urachal lumen can lead to a urachal fistula, urachal cyst, or urachal sinus. In some patients, this epithelium can undergo metaplasia to become glandular epithelium. The result may be malignancy, usually mucinous adenocarcinoma. Most (90%) urachal carcinomas are juxtavesical, specifically, supravesical, anterior to the bladder, or in its midline.

Presentation

Patients can have mucous micturition, although this occurs in only 25% of patients. More commonly, hematuria is present in as many as 75% of patients. Uncommonly, blood, pus, or mucus can drain from the umbilicus. Nonspecific abdominal pain is often a symptom.

Preferred Examination

CT is the best modality to depict urachal carcinoma, although MRI can be helpful in select patients. MRI is helpful for the evaluation of the fluid or mucous content of the urachal segment and for multiplanar depiction of the carcinoma. In most cases, CT is sufficient.

Differential Diagnoses

Transitional Cell Carcinoma

Contents

Overview: Urachal Carcinoma
Imaging: Urachal Carcinoma
Follow-up: Urachal Carcinoma
Multimedia: Urachal Carcinoma

References

  1. Blute ML, Engen DE, Travis WD, Kvols LK. Primary signet ring cell adenocarcinoma of the bladder. J Urol. Jan 1989;141(1):17-21. [Medline].

  2. Brick SH, Friedman AC, Pollack HM, et al. Urachal carcinoma: CT findings. Radiology. Nov 1988;169(2):377-81. [Medline].

  3. Gill HS, Dhillon HK, Woodhouse CR. Adenocarcinoma of the urinary bladder. Br J Urol. Aug 1989;64(2):138-42. [Medline].

  4. Jakse G, Schneider HM, Jacobi GH. Urachal signet-ring cell carcinoma, a rare variant of vesical adenocarcinoma: incidence and pathological criteria. J Urol. Dec 1978;120(6):764-6. [Medline].

  5. Korobkin M, Cambier L, Drake J. Computed tomography of urachal carcinoma. J Comput Assist Tomogr. Nov-Dec 1988;12(6):981-7. [Medline].

  6. Narumi Y, Sato T, Kuriyama K, et al. Vesical dome tumors: significance of extravesical extension on CT. Radiology. Nov 1988;169(2):383-5. [Medline].

  7. Sheldon CA, Clayman RV, Gonzalez R, et al. Malignant urachal lesions. J Urol. Jan 1984;131(1):1-8. [Medline].

  8. Thomas AJ, Pollack MS, Libshitz HI. Urachal carcinoma: evaluation with computed tomography. Urol Radiol. 1986;8(4):194-8. [Medline].

  9. el-Mekresh MM, el-Baz MA, Abol-Enein H, Ghoneim MA. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br J Urol. Aug 1998;82(2):206-12. [Medline].

Further Reading

Keywords

urachal adenocarcinoma, urachus carcinoma, bladder cancer, bladder adenocarcinoma, bladder carcinoma, urachal cancer

Contributor Information and Disclosures

Author

Robert L Cirillo Jr, MD, MBA, Assistant Professor of Radiology, Florida State University College of Medicine; Medical Interventional Radiologist, Director/CEO, South Georgia Vascular Institute and South Georgia Laser Vein Center
Robert L Cirillo Jr, MD, MBA is a member of the following medical societies: American College of Physician Executives, Cardiovascular and Interventional Radiological Society of Europe, Society for Vascular Technology, and Society of Interventional Radiology
Disclosure: Nothing to disclose

Medical Editor

Steven Perlmutter, MD, FACR, Clinical Associate Professor, Radiology Residency Program Director, Radiology Medical Director, Department of Radiology, University Hospital at Stony Brook
Steven Perlmutter, MD, FACR is a member of the following medical societies: American College of Radiology, American Institute of Ultrasound in Medicine, American Medical Association, American Roentgen Ray Society, Association of Program Directors in Radiology, Association of University Radiologists, Medical Society of the State of New York, Radiological Society of North America, Society of Breast Imaging, Society of Nuclear Medicine, and Society of Uroradiology
Disclosure: Nothing to disclose

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose

Managing Editor

Arnold C Friedman, MD, FACR, Associate Chairman, Department of Radiology, University of Florida Health Science Center; Chief, Department of Radiology, Shands-Jacksonville Hospital
Arnold C Friedman, MD, FACR is a member of the following medical societies: American College of Radiology, American Institute of Ultrasound in Medicine, American Roentgen Ray Society, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose

Chief Editor

Eugene C Lin, MD, Consulting Staff, Department of Radiology, Virginia Mason Medical Center
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, and Society of Nuclear Medicine
Disclosure: Nothing to disclose

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.